Skip to main content

Recall of Maxrin Cap 0.4mg

  • 2014.09.05

The Department of Health (DH) today (Sept 5) instructed a licensed drug wholesaler, Champion Healthcare Limited (Champion), to recall all batches of Maxrin Cap 0.4mg (registration number: HK-59215) from the market because the product had been released based on specifications different from the registered specifications.

During DH's market surveillance, samples of the product were collected for evaluation and it was found that the manufacturer of the product has revised the release specifications without notifying Champion. Change in product specifications without prior approval from the Pharmacy and Poisons Board would render the product unregistered under the Pharmacy and Poisons Ordinance (Cap 138).

Maxrin Cap 0.4mg, containing Tamsulosin, is a prescription medicine used for the treatment of benign prostatic hyperplasia. It can only be sold at pharmacies under the supervision of a registered pharmacist upon a doctor's prescription.

According to Champion, the product has been supplied to private doctors and local pharmacies. Champion has set up a hotline (2414 8393) for related enquiries. DH will closely monitor the recall.

“Members of the public should consult their healthcare professionals for advice if in doubt,” a DH spokesman advised.